Scientific Information

INVITED SPEAKERS

Please note that the list of Invited Speakers is subject to change, and will be updated continuously.

Massimo Levrero

Professor Levrero is Professor of Medicine at the Sapienza University in Rome, Italy. He has recently joined the Centre de Recherche en Cancérologie de Lyon (CRCL) in Lyon, France, where he leads a Research Unit on ”Epigenetics and Epigenomics of Hepatocellular Carcinoma”, and the Service d’Hepatologie et Gastroenterologie - Hopital de la Croix Rousse - Hospices Civils de Lyon, France, where he continues his academic practice in hepatology. He serves as Associate Member and Director of the Functional Genomics platform at the IIT-Sapienza Center for Life NanoScience (CLNS) in Rome

Italy

Sharon Lewin
Prof Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Medicine, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She is passionate about research translation, science communication and the role of community in research and health.
Australia

Lim Seng Gee
Prof Lim is Director of Hepatology, Dept of Gastroenterology & Hepatology National University Hospital, Chairman of the Singapore Hepatitis Conference, Governing Council Member, International Association for Study of Liver; and Adjunct Principal Investigator, Institute of Molecular and Cell Biology, ASTAR
Singapore

Stephen Locarnini
Prof Locarnini is a Head of Department at Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, University of Melbourne, WHO Regional Reference Laboratory for Hepatitis B. His research interests include Hepatitis A, B, C, D, E, public health, co-infection with HIV, pathogenesis, cure strategies.
Australia

Stephan Urban
Professor at Department of Infectious Diseases, Molecular Virology, University Heidelberg. His research interests include molecular mechanisms of Hepatitis B and Hepatitis D Virus/host interactions with a focus on the early events of infection and development of hepatotropic drugs for the therapy of liver diseases
Germany

Peter Revill
Professor Revill is a Senior Medical Scientist at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Section Head of the Molecular Virology Group, Division of Research and Molecular Development and the President of Australasian Centre for Hepatitis Virology.
Australia

Robert Thimme
Prof Thimme is the Director of the Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases). His research focus lies on the immune responses in hepatitis B virus (HBV) and hepatitis C virus (HCV) infection as well as hepatocellular carcinoma (HCC). His main focuses are the immunological determinants of viral clearance and persistence with a special focus on CD8+ T cells.
Germany

Alex Thompson
Professor-Director of the Department of Gastroenterology at St Vincent’s Hospital and the University of Melbourne, Australia and an Adjunct Assistant Professor of the Department of Gastroenterology, Duke University Medical Center. His research focusses on improving outcomes for people living with viral hepatitis. He was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV, and is an active clinical investigator for trials evaluating the efficacy of novel antiviral DAA regimens
Australia